Verseau Therapeutics

Verseau Therapeutics

Verseau Therapeutics

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators (MCMs), to benefit patients with cancer, immune and inflammatory diseases.
Raised
$50M
Follow us
Alexa global traffic share
Twitter followers
Team Size
1–10
Employees
$50,000,000 Undisclosed
DealStreetAsia , WSJ Venture Capital

China’s 3SBio, Highlight Capital, Yonghua back $50m Verseau Therapeutics round